Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons.
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Regulatory Pathway for Licensing Biotherapeutics in Mexico. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 6 de septiembre de 2022 In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 28 de agosto de 2022 Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies Ver más
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection....
-
UDIBI
admin_udibi3, , Sin categorizar, 0
The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer. VER...